MCID: TRC008
MIFTS: 47

Trachoma malady

Categories: Rare diseases, Infectious diseases

Aliases & Classifications for Trachoma

About this section

Aliases & Descriptions for Trachoma:

Name: Trachoma 11 48 50 39 13 68
Trachoma, Initial Stage 68
Trachoma, Active Stage 68
 
Active Stage Trachoma 11
Trachoma Dubium 11

Classifications:



Summaries for Trachoma

About this section
Disease Ontology:11 A commensal bacterial infectious disease that results in infection located in eye, has material basis in Chlamydia trachomatis (A, B, Ba and C serovars), which is transmitted by contact with eye discharge from the infected person and transmitted by congenital method. The infection causes eyelid to turn inward which makes eyelashes to scratch the cornea.

MalaCards based summary: Trachoma, also known as trachoma, initial stage, is related to entropion and onchocerciasis. An important gene associated with Trachoma is KIR2DL3 (Killer Cell Immunoglobulin Like Receptor, Two Ig Domains And Long Cytoplasmic Tail 3), and among its related pathways are amb2 Integrin signaling and IL-15 Signaling Pathways and their Primary Biological Effects in Different Immune Cell Types. The drugs sulfacetamide and sulfisoxazole diolamine have been mentioned in the context of this disorder. Affiliated tissues include eye, eye and testes.

Wikipedia:71 Trachoma is an infectious disease caused by bacterium Chlamydia trachomatis. The infection causes a... more...

Related Diseases for Trachoma

About this section

Diseases related to Trachoma via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 98)
idRelated DiseaseScoreTop Affiliating Genes
1entropion11.2
2onchocerciasis11.2
3chlamydia10.5
4conjunctivitis10.4
5inclusion conjunctivitis10.3
6lymphogranuloma venereum10.2
7hereditary night blindness10.2CTGF, TNF
8kernicterus due to isoimmunization10.2HLA-C, TNF
9pyridoxal 5'-phosphate-dependent epilepsy10.1IL10, TNF
10tubular renal disease-cardiomyopathy syndrome10.1IL10, TNF
11lagophthalmos10.1IL10, TNF
12multiple vertebral anomalies unusual facies10.1IL10, TNF
13conidiobolomycosis10.1IL10, TNF
14endosalpingiosis10.1IL10, TNF
15severe combined immunodeficiency, t cell-negative, b-cell/natural killer-cell positive10.1IL10, TNF
16idiopathic hypertrophic pachymeningitis10.1IL10, TNF
17infantile hypotonia10.1IDO1, TNF
18transient tic disorder10.1IL10, TNF
19vestibule of mouth cancer10.1IL10, TNF
20plantar wart10.1IL10, TNF
21osteodysplasty precocious of danks mayne and kozlowski10.1IL10, TNF
22parkinson disease 1110.1IL10, TNF
23cyclosporiasis10.1IL10, TNF
24hypoparathyroidism-retardation-dysmorphism syndrome10.1IL10, TNF
25congenital hypothyroidism10.1IL10, TNF
26sarcomatoid transitional cell carcinoma10.1IL10, TNF
27neurotic disorder10.1IL10, TNF
28trichomalacia10.1IL10, TNF
29senile reticular retinal degeneration10.1IL10, TNF
30conduct disorder10.1IL10, TNF
31gastric dilatation10.1IL10, TNF
32pancreatic signet ring cell adenocarcinoma10.1IL10, TNF
33megaloblastic anemia10.1IDO1, IL10
34pulpitis10.1IL10, TNF
35tularemia10.1IL10, TNF
36chronic thromboembolic pulmonary hypertension10.1IDO1, IL10
37rheumatoid factor-negative juvenile idiopathic arthritis without anti-nuclear antibodies10.1IL10, TNF
38pseudo-meigs syndrome10.1IL10, TNF
39gonococcal endophthalmia10.0IL10, TNF
40ectodermal dysplasia bartalos type10.0IL10, TNF
41primary ciliary dyskinesia10.0IL10, TNF
42cryptococcosis10.0IL10, TNF
43hereditary alpha tryptasemia syndrome10.0IL10, TNF
44rickettsialpox10.0IL10, TNF
45autosomal recessive type iv ehlers-danlos syndrome10.0IL10, TNF
46astrocytoma10.0IL10, TNF
47bladder signet ring cell adenocarcinoma10.0IL10, TNF
48acute myeloid leukemia with recurrent genetic anomaly10.0IL10, TNF
49erb-duchenne and dejerine-klumpke palsies10.0IL10, TNF
50microcephaly10.0IL10, TNF

Graphical network of the top 20 diseases related to Trachoma:



Diseases related to trachoma

Symptoms & Phenotypes for Trachoma

About this section

Drugs & Therapeutics for Trachoma

About this section

Drugs for Trachoma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 25)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
Permethrinapproved, investigationalPhase 43452645-53-140326
Synonyms:
(+)-CIS-PERMETHRIN
(+)-trans-Permethrin
(+-)-cis-Fmc 33297
(+-)-cis-Permethrin
(+-)-trans-Permethrin
(3-Phenoxyphenyl)methyl (+-)-cis,trans-3-(2,2-dichloroethenyl)-2,2-dimethylcyclopropanecarboxylate
(3-phenoxyphenyl)methyl 3-(2,2-dichloroethenyl)-2,2-dimethylcyclopropane-1-carboxylate
1RS,cis-Permethrin
1RS-trans-Permethrin
3-(2,2-Dichloroethenyl)-2,2-dimethylcyclopropane carboxylic acid, (3-phenoxyphenyl) methyl ester
3-Phenoxybenzyle (1RS)-cis, trans-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropane carboxylate
3-phenoxybenzyl 3-(2,2-dichloroethenyl)-2,2-dimethylcyclopropanecarboxylate
442748_SUPELCO
45614_FLUKA
45614_RIEDEL
45893_FLUKA
45893_RIEDEL
47956_SUPELCO
52341-32-9
52341-33-0
52645-53-1
AC1L23IC
AC1Q3FFG
AI3-29296
Acticin Cream
Ambush
BRN 4153590
C21H20Cl2O3
CHEBI:34911
CHEMBL1525
CID40326
 
DB04930
Elimite Cream
FMC 35171
LS-58636
LS-58640
MLS001332525
MLS001332526
MolPort-003-933-021
NCGC00159390-00
NCGC00159390-02
NCGC00159390-04
NCGC00159390-05
NCGC00159390-06
NCGC00159390-07
NCGC00159390-08
NCGC00159390-09
NRDC 146
NRDC 148
Nix Cream Rinse
PS758_SUPELCO
PerFoam
Permethrin
Permethrin (isomers)
Permethrin (isomers) solution
Permethrine,c&t
SMR000778043
ST50975270
TL8003462
Transpermethrin
Transpermethrin [ISO]
[3-(phenyloxy)phenyl]methyl 3-(2,2-dichloroethenyl)-2,2-dimethylcyclopropanecarboxylate
trans-(+-)-Permethrin
2
AzithromycinapprovedPhase 4, Phase 3, Phase 234683905-01-555185, 53477736, 447043
Synonyms:
(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-11-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-3,4,10-trihydroxy-13-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,6,8,10,12,14-heptamethyl-1-oxa-6-azacyclopentadecan-15-one
(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-13-((2,6-Dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranosyl)oxy)-2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-11-((3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyl)oxy)-1-oxa-6-azacyclopentadecan-15-one
(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-15-oxo-11-{[3,4,6-trideoxy-3-(dimethylamino)-b-D-xylo-hexopyranosyl]oxy}-1-oxa-6-azacyclopentadecan-13-yl 2,6-dideoxy-3-C-methyl-3-O-methyl-a-L-ribo-hexopyranoside
(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-15-oxo-11-{[3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyl]oxy}-1-oxa-6-azacyclopentadecan-13-yl 2,6-dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranoside
(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)13-((2,6-Dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranosyl)oxy)-2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-11-((3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyl)oxy)-1-oxa-6-azacyclopentadecan-15-one
1-Oxa-6-azacyclopentadecan-15-one, 13-((2,6-dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranosyl)oxy)-2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-11-((3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyl)oxy)-,(2R-(2R*,3S*
121470-24-4
75199_FLUKA
83905-01-5
9-Deoxo-9a-aza-9a-methyl-9a-homoerythromycin A
AC-16014
AC1L9KEG
Aritromicina
Azasite
Azenil
Azifast
Azigram
Azimakrol
Azithramycine
Azithromycin
Azithromycin & Tumor Necrosis Factor
Azithromycin (AIDS Initiative)
Azithromycin (anhydrous)
Azithromycin Dihydrate
Azithromycin Monohydrate
Azithromycin Sterile
Azithromycin dihydrate
Azithromycin plus Tumor Necrosis Factor
Azithromycine
Azithromycine [French]
Azithromycinum
Azithromycinum [Latin]
Azitrocin
Azitromax
Azitromicina
Azitromicina [Spanish]
Azitromin
Azythromycin
BIDD:GT0792
BRN 5387583
BSPBio_002285
Bio-0676
C38H72N2O12
CCRIS 1961
CHEBI:2955
CHEMBL529
CID447043
CP-62993
CP62,993
CPD000471864
DCH3
DRG-0104
 
DivK1c_000233
HMS1922G12
HMS2094M11
HMS500L15
HSDB 7205
Hemomycin
IDI1_000233
KBio1_000233
KBio2_000787
KBio2_003355
KBio2_005923
KBio3_001505
KBioGR_000731
KBioSS_000787
LS-1834
MLS001055353
MLS001066331
MLS001201763
MLS001304005
MLS001332499
MLS001332500
Misultina
MolPort-002-507-426
N,N-Dimethyl-4-amino-benzaldehyde
NCGC00090753-01
NCGC00090753-02
NINDS_000233
NSC643732
SAM002589961
SMR000471864
SPBio_001544
SPECTRUM1503679
Spectrum2_001582
Spectrum3_000653
Spectrum4_000186
Spectrum5_001867
Spectrum_000307
Sumamed
Tromix
UNII-JTE4MNN1MD
XZ-450
Z-Pak
ZIT
Zentavion
Zithromac
Zithromax
Zithromax IV
Zithromycin
Zitromax
Zitromax Avium 600
Zmas
Zmax
azithromycin
3
Albendazoleapproved, vet_approvedPhase 48554965-21-82082
Synonyms:
((Propylthio)-5 1H-benzimidazolyl-2) carbamate de methyle
((Propylthio)-5 1H-benzimidazolyl-2) carbamate de methyle [French]
(5-(Propylthio)-1H-benzimidazol-2-yl)carbamic acid methyl ester
(5-Propylsulfanyl-1H-benzoimidazol-2-yl)-carbamic acid methyl ester
5-(Propylthio)-2-carbomethoxyaminobenzimidazole
54965-21-8
A4673_FLUKA
A4673_SIGMA
AB00052377
AC-015
AC1L1CVL
AC1Q2YKD
AKOS000540882
Albendazol
Albendazol [INN-Spanish]
Albendazole
Albendazole (JAN/USP/INN)
Albendazole Armstrong Brand
Albendazole Diba Brand
Albendazole Fustery Brand
Albendazole Hormona Brand
Albendazole Liferpal Brand
Albendazole Monohydrochloride
Albendazole Noe-Socopharm Brand
Albendazole Pfizer Brand
Albendazole Sanicoopa Brand
Albendazole Valdecasas Brand
Albendazole [USAN:INN:BAN:JAN]
Albendazolum
Albendazolum [INN-Latin]
Albendoral
Albenza
Albenza (TN)
Albenza, Eskazole, Zentel, Andazol, Albendazole
Armstrong Brand of Albendazole
BAS 00439961
BB_SC-1386
BIDD:GT0615
BIM-0051849.0001
BPBio1_000038
BRD-K79131256-001-04-7
BSPBio_000034
BSPBio_002548
Bendapar
Bilutac
C01779
CARBAMIC ACID, (5-(PROPYLTHIO)-1H-BENZIMIDAZOL-2-YL)-, METHYL ESTER
CAS-54965-21-8
CHEBI:16664
CHEBI:506787
CHEMBL1483
CID2082
CPD000036735
Carbamic acid, [5-(propylthio)-1H-benzimidazol-2-yl]-, methyl ester
ChemDiv1_000190
ChemDivAM_000003
D00134
D015766
DB00518
Diba Brand of Albendazole
Digezanol
Disthelm
Disthelm, Mediamix V
DivK1c_000704
EINECS 259-414-7
Endoplus
Eskazole
Fustery Brand of Albendazole
Gascop
HMS1568B16
HMS1922K04
HMS2090G19
HMS2093K13
HMS502D06
HMS587I14
HSDB 7444
Hormona Brand of Albendazole
I01-0380
IDI1_000704
InChI=1/C12H15N3O2S/c1-3-6-18-8-4-5-9-10(7-8)14-11(13-9)15-12(16)17-2/h4-5,7H,3,6H2,1-2H3,(H2,13,14,15,16)
KBio1_000704
 
KBio2_002012
KBio2_004580
KBio2_007148
KBioGR_000801
KBioSS_002012
LS-50618
Liferpal Brand of Albendazole
Lurdex
MLS000069722
Mediamix V Disthelm
Methyl 5-(propyl-thio)-2-benzimidazolecarbamate
Methyl 5-(propylthio)-2-benzimidazolecarbamate
Methyl [5-(Propylthio)benzimidazol-2-yl]carbamate
Methyl-5-[propylthio]-2-benzimidazole carbamate
Metiazol
MolPort-000-726-929
MolPort-000-760-571
MolPort-001-932-918
Monohydrochloride, Albendazole
NCGC00016876-01
NCGC00016876-02
NCGC00022896-03
NCGC00022896-04
NCGC00022896-05
NCGC00022896-06
NCGC00022896-07
NINDS_000704
NSC 220008
NSC220008
Noe Socopharm Brand of Albendazole
Noe-Socopharm Brand of Albendazole
O-Methyl N-(5-(propylthio)-2-benzimidazolyl)carbamate
Oprea1_429292
Oprea1_585016
Oprea1_640007
Pfizer Brand of Albendazole
Prestwick0_000247
Prestwick1_000247
Prestwick2_000247
Prestwick3_000247
Prestwick_675
Proftril
Ricobendazole
Rycobendazole
S1640_Selleck
SAM002589939
SK&F 62979
SK&F-62979
SK&F62979
SKF 62979
SKF-62979
SKF62979
SMR000036735
SPBio_002253
SPECTRUM1503903
STK387550
STL046130
STOCK2S-67946
Sanicoopa Brand of Albendazole
Smith Kline & French Brand of Albendazole
SmithKline Beecham Brand of Albendazole
Spectrum4_000201
Spectrum5_001567
Spectrum_001532
TL8003543
UNII-F4216019LN
V Disthelm, Mediamix
VU0239747-6
Valbazen
Valdecasas Brand of Albendazole
ZINC17146904
Zental
Zentel
[5-(Propylthio)benzimidazol-2-yl]carbamic Acid Methyl Ester
[5-(Propythio)-1H-benzimidazol-2-yl]carbamic acid methyl ester
albendazole
methyl N-(6-propylsulfanyl-1H-benzimidazol-2-yl)carbamate
methyl N-[6-(propylsulfanyl)-1H-1,3-benzodiazol-2-yl]carbamate
methyl [(2Z)-5-(propylsulfanyl)-1,3-dihydro-2H-benzimidazol-2-ylidene]carbamate
methyl [5-(propylsulfanyl)-1H-benzimidazol-2-yl]carbamate
methyl [5-(propylthio)-1H-benzimidazol-2-yl]carbamate
methyl [6-(propylsulfanyl)-1H-benzimidazol-2-yl]carbamate
4
Ivermectinapproved, vet_approvedPhase 46170288-86-76474909, 46936176
Synonyms:
(2aE,4E,5'S,6S,6'R,7S,8E,11R,13R,15S,17aR,20R,20aR,20bS)-20,20b-dihydroxy-5',6,8,19-tetramethyl-6'-[(1S)-1-methylpropyl]-17-oxo-3',4',5',6,6',10,11,14,15,17,17a,20,20a,20b-tetradecahydro-2H,7H-spiro[11,15-methanofuro[4,3,2-pq][2,6]benzodioxacyclooctadecine-13,2'-pyran]-7-yl 2,6-dideoxy-4-O-(2,6-dideoxy-3-O-methyl-alpha-L-arabino-hexopyranosyl)-3-O-methyl-alpha-L-arabino-hexopyranoside
22,23-Dihydroxy-avermectin B
22,23-Dihyroavermectin B1
5-O-Demethyl-22,23-dihydro-avermectin A1a
71827-03-7
AB00513813
AC1MJ4GR
AC1N7O27
BPBio1_000322
BRD-K24652731-001-02-7
BSPBio_000292
CHEMBL341047
CID11957587
CID4330618
CID6321424
CID6419971
CID6427057
EU-0100693
FT-0082656
HMS1568O14
 
HMS2089M09
I 8898
I8898_SIGMA
IVERMECTIN
Ivermectin
Ivermectina
Ivermectine
Ivermectinum
Lopac0_000693
MK-933
MLS001333247
MLS001333248
MLS002153248
MolPort-006-394-715
NCGC00094047-01
NCGC00094047-02
NCGC00094047-03
Prestwick2_000156
Prestwick3_000156
Prestwick_516
S1351_Selleck
SMR000857211
5
Tetracyclineapproved, vet_approvedPhase 410560-54-85353990
Synonyms:
(-)-Tetracycline
(4S,4AS,5as,12as)-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide
6-Methyl-1,11-dioxy-2-naphthacenecarboxamide
60-54-8
64-75-5 (mono-hydrochloride)
6591-49-7
87128_FLUKA
87128_SIGMA
AC-13151
AC1L1KAT
AC1NQXT7
AC1NRDAM
AC1NS4RQ
AC1NSDX8
AC1NTUT2
AC1NUZHL
AC1O52HS
Abramycin
Abricycline
Achromycin
Achromycin (naphthacene derivative)
Achromycin V
Achromycin, naphthacene derivative
Agromicina
Ambramicina
Ambramycin
Amycin
Anhydrotetracycline
BIDD:GT0653
BPBio1_000242
BSPBio_000220
BSPBio_001950
Bio-tetra
Biocycline
Bristaciclin
Bristaciclin .alpha.
Bristaciclina
Bristacycline
C06570
CHEBI:27902
CHEMBL1440
CID12309720
CID5280962
CID5289435
CID5353990
CID5359245
CID5388997
CID5412
CID5497101
CID6426717
Cefracycline
Cefracycline suspension
Centet (base)
Ciclibion
Copharlan
Criseociclina
Cyclomycin
Cyclopar
Cytome
D00201
DB00759
Democracin
Deschlorobiomycin
DivK1c_000827
Dumocyclin
EINECS 200-481-9
Enterocycline
HMS2090B04
HSDB 3188
Hostacyclin
IDI1_000827
KBio1_000827
KBio2_001514
KBio2_004082
KBio2_006650
KBio3_001450
KBioGR_000783
KBioSS_001514
LS-187078
LS-93869
Lemtrex (base)
Lexacycline
Limecycline
Liquamycin
Liquamycin (Veterinary)
 
Liquamycin, veterinary
MLS000069728
Medocycline
Mericycline
Micycline
MolPort-001-794-633
MolPort-003-983-460
MolPort-005-934-198
NCGC00161665-01
NINDS_000827
NSC 108579
NSC108579
Neocycline
Omegamycin
Orlycycline
Panmycin
Piracaps (base)
Polycycline
Polycycline (VAN)
Polycycline (antibiotic)
Polycycline, antibiotic
Polyotic
Prestwick0_000140
Prestwick1_000140
Prestwick2_000140
Prestwick3_000140
Purocyclina
Resteclin
Robitet
Roviciclina
SK-Tetracycline
SMR000058220
SPBio_001457
SPBio_002159
STOCK1N-42738
Sanclomycine
Solvocin
Spectrum2_001329
Spectrum3_000565
Spectrum4_000352
Spectrum5_001112
Spectrum_001034
Sumycin
Sumycin (TN)
Sumycin syrup
T-125
T3258_SIGMA
Tetra-Co
Tetrabon
Tetrachel
Tetraciclina
Tetraciclina [INN-Spanish]
Tetracycl
Tetracyclin
Tetracycline & VRC3375
Tetracycline (JAN/USP/INN)
Tetracycline (internal use)
Tetracycline Free Base
Tetracycline HCl
Tetracycline I
Tetracycline II
Tetracycline Monohydrochloride
Tetracycline [USAN:INN:BAN:JAN]
Tetracyclinum
Tetracyclinum [INN-Latin]
Tetracyn
Tetradecin
Tetrafil
Tetraverine
Tetrazyklin
Topicycline
Tsiklomistsin
Tsiklomitsin
Tétracycline
UNII-F8VB5M810T
UPCMLD-DP127
UPCMLD-DP127:001
UPCMLD-DP127:002
Veracin
Vetacyclinum
Vetquamycin-324 (free base)
WLN: L E6 C666 BV FV CU GUTTT&J DQ EQ GVZ HQ IN1&1 MQ M1 RQ
component of Tetrastatin
methyl-1,11-dioxo-2-naphthacenecarboxamide
nchembio.273-comp1
nchembio.289-comp1
tetracycline
6
MentholapprovedPhase 426062216-51-516666
Synonyms:
(−
()-Menthol
(+)-Neo-menthol
(+)-p-Menthan-3-ol
(+-)-(1R*,3R*,4S*)-Menthol
(+-)-Menthol
(+/-)-Menthol
(+/-)-p-Menthan-3-ol
(-)-(1R,3R,4S)-Menthol
(-)-Menthyl alcohol
(-)-menthol
(-)-p-Menthan-3-ol
(-)-trans-p-Menthan-cis-ol
(1R)-(-)-Menthol
(1R,2S,5R)-(-)-menthol
(1R,2S,5R)-Menthol
(1R,3R,4S)-(-)-MENTHOL
(1R,3R,4S)-(-)-Menthol
(1R-(1-alpha,2-beta,5-alpha))-5-Methyl-2-(1-methylethyl)cyclohexanol
(1S, 2S, 5R)-(+)-Neomenthol
(1S,2R,5R)-(+)-Isomenthol
(1S,2R,5S)-(+)-Menthol
(1S,2R,5S)-Menthol
(1alpha,2beta,5alpha)-5-Methyl-2(1-methylethyl)cyclohexanol
(1r,2s,5r)-(-)-menthol
(L)-MENTHOL
(R)-(-)-Menthol
(r)-(-)-menthol
)-Menthol
--MENTHOL
1-Menthol
1490-04-6
15356-60-2
15356-70-4
15785_RIEDEL
15785_SIAL
19863P
2-Isopropyl-5-methylcyclohexanol
20747-49-3
2216-51-5
3-p-Menthol
4-Isopropyl-1-methylcyclohexan-3-ol
491-02-1
5-Methyl-2-(1-methylethyl)-cyclohexanol
5-Methyl-2-(1-methylethyl)cyclohexanol
5-methyl-2-(propan-2-yl)cyclohexanol
5-methyl-2-propan-2-ylcyclohexan-1-ol
551376_ALDRICH
551376_FLUKA
588733_ALDRICH
613290_ALDRICH
613290_FLUKA
63660_FLUKA
63670_ALDRICH
63670_FLUKA
63975-60-0
6C6A4A8C-A054-468C-A1F0-F29E39838CF2
89-78-1
98167-53-4
AC1L1B2E
AC1L28FR
AC1Q1NQ2
AC1Q2QQM
AI3-08161
AI3-52408
AKOS000119740
AR-1J3337
BB_NC-0057
BRN 1902288
BRN 3194263
BSPBio_003062
C00400
C10H20O
CCRIS 3728
CCRIS 375
CCRIS 4666
CCRIS 9231
CHEBI:15409
CHEBI:545611
CHEMBL256087
CHEMBL470670
CID1254
CID16666
Caswell No. 540
D-(-)-Menthol
D-p-Menthan-3-ol
D00064
D008610
D04849
D04918
DB00825
DivK1c_000820
EINECS 201-939-0
EINECS 207-724-8
EINECS 216-074-4
EINECS 218-690-9
EINECS 239-387-8
EINECS 239-388-3
EPA Pesticide Chemical Code 051601
FEMA No. 2665
Fisherman's friend lozenges
Fisherman's friend lozenges (TN)
HMS1922G13
HMS2092L14
HMS502I22
 
HSDB 5662
HSDB 593
Headache crystals
Hexahydrothymol
I06-1216
I14-7371
IDI1_000820
KBio1_000820
KBio2_000785
KBio2_003353
KBio2_005921
KBio3_002562
KBioSS_000785
L-(-)-Menthol
L-(-)-menthol
L-Menthol
L-menthol
LMPR0102090001
LS-2353
LS-57201
LS-886
LS-89531
LS-89533
Levomenthol
Levomenthol [INN:BAN]
Levomentholum
Levomentholum [INN-Latin]
Levomentol
M0321
M0545
M2772_SIAL
MENTHOL
MLS002207256
Menthacamphor
Menthol
Menthol (USP)
Menthol (VAN)
Menthol natural
Menthol natural, brazilian
Menthol racemic
Menthol racemique
Menthol racemique [French]
Menthol solution
Menthol, (1alpha,2beta,5alpha)-Isomer
Menthomenthol
Menthyl alcohol
MolPort-000-849-729
MolPort-001-793-392
NCGC00159382-02
NCGC00159382-03
NCGC00164247-01
NCGC00164247-02
NCI-C50000
NINDS_000820
NOOLISFMXDJSKH-KXUCPTDWBX
NSC 2603
NSC 62788
NSC2603
NSC62788
Neoisomenthol
Peppermint camphor
RACEMIC MENTHOL U.S.P.
Racementhol
Racementhol [INN:BAN]
Racementholum
Racementholum [INN-Latin]
Racementol
Racementol [INN-Spanish]
Racemic menthol
Robitussin Cough Drops
SDCCGMLS-0066659.P001
SMR001306785
SPBio_000869
SPECTRUM1503134
STK802468
Spectrum2_000855
Spectrum3_001561
Spectrum5_001060
Spectrum_000305
Tra-kill tracheal mite killer
U.S.P. Menthol
U.S.p. Menthol
UNII-BZ1R15MTK7
UNII-L7T10EIP3A
UNII-YS08XHA860
W266507_ALDRICH
W266523_ALDRICH
W266590_ALDRICH
WLN: L6TJ AY1&1 BQ D1
WLN: L6TJ AY1&1 DQ D1 -L
ZINC01482164
cis-1 ,3-trans-1,4-(+-)-menthol
cis-1,3-trans-1,4-(+-)-menthol
d,l-Menthol
d-Menthol
d-Neomenthol
dl-3-p-Menthanol
dl-Menthol
dl-Menthol (JP15)
l-(-)-Menthol
l-Menthol
l-Menthol (JP15)
l-Menthol (TN)
l-Menthol (natural)
nchembio862-comp1
p-Menthan-3-ol
rac-Menthol
7Anti-Bacterial AgentsPhase 4, Phase 2, Phase 311226
8Antibiotics, AntitubercularPhase 4, Phase 2, Phase 37180
9Anti-Infective AgentsPhase 422062
10Antiprotozoal AgentsPhase 42051
11AnthelminticsPhase 4446
12Antiparasitic AgentsPhase 42199
13Antimitotic AgentsPhase 45657
14Antitubercular AgentsPhase 41343
15TetrahydrozolinePhase 3621
16Pharmaceutical SolutionsPhase 38192
17Ophthalmic SolutionsPhase 31140
18
Fluorometholoneapproved20426-13-19878
Synonyms:
(1R,2S,8S,10S,11S,14R,15S,17S)-14-acetyl-1-fluoro-14,17-dihydroxy-2,8,15-trimethyltetracyclo[8.7.0.02,7.011,15]heptadeca-3,6-dien-5-one
(6S,8S,9R,10S,11S,13S,14S,17R)-17-acetyl-9-fluoro-11,17-dihydroxy-6,10,13-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one
11beta,17alpha-Dihydroxy-9-fluoro-6-methyl-1,4-pregnadiene-3,20-dione
426-13-1
9-Fluoro-11,17-dihydroxy-6-methylpregna-1,4-diene-3,20-dione
9-Fluoro-11-beta,17-dihydroxy-6-alpha-methylpregna-1,4-diene-3,20-dione
9-Fluoro-11beta,17-dihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione
AC-3520
AC1L1U0Y
AI3-52813
Alcon Brand of Fluorometholone
Allergan Brand 1 of Fluorometholone
Allergan Brand 2 of Fluorometholone
Allergan Brand 3 of Fluorometholone
BPBio1_001029
BRD-K64862097-001-03-9
BSPBio_000935
CHEMBL1200600
CID9878
Cortilet
Cortisdin
D005469
D01367
DB00324
Delmeson
EINECS 207-041-5
Efflumidex
F0414
F9381_SIGMA
FML
FML Forte
FML Liquifilm
FML S.O.P
FML-S Liquifilm
Fluaton
Flucon
Flucon, Isopto
Flumetholon
Fluor Op
Fluor-OP
Fluor-Op
Fluor-op (TN)
Fluormetholon
Fluormetholone
Fluormetholonum
Fluoro Ophtal
Fluoro-Ophtal
Fluoromethalone
Fluorometholon
Fluorometholone
 
Fluorometholone (JP15/USP/INN)
Fluorometholone [INN:BAN:JAN]
Fluorometholonum
Fluorometholonum [INN-Latin]
Fluorometolona
Fluorometolona [INN-Spanish]
Fluorometolone
Fluorometolone [DCIT]
Fluorométholone
Fluoropos
Fml (TN)
HMS1570O17
Isdin Brand of Fluorometholone
Isopto Flucon
LS-118455
Loticort
MLS000069537
MLS001076157
MolPort-003-941-413
NCGC00021575-03
NCI60_002886
NSC 33001
NSC-33001
NSC33001
Neo-Oxylone
Novartis Brand of Fluorometholone
Oxylone
Oxylone (TN)
PMS Fluorometholone
PMS-Fluorometholone
Pharm Allergan Brand of Fluorometholone
Pharm-Allergan Brand of Fluorometholone
Pharmascience Brand of Fluorometholone
Pregna-1,4-diene-3,20-dione, 9-fluoro-11.beta.,17
Pregna-1,4-diene-3,20-dione, 9-fluoro-11beta,17-dihydroxy-6alpha-methyl- (8CI)
Prestwick0_000718
Prestwick1_000718
Prestwick2_000718
Prestwick3_000718
Prestwick_227
SMR000058598
SPBio_002856
Trilcin
U 8614
UNII-SV0CSG527L
Ursapharm Brand of Fluorometholone
Ursnon
Winzer Brand of Fluorometholone
ZINC03876158
component of Neo-Oxylone
fluorometholone
19Hormones, Hormone Substitutes, and Hormone Antagonists13168
20Lubricant Eye Drops168
21Hormones14415
22glucocorticoids5103
23Anti-Allergic Agents1522
24Anti-Inflammatory Agents10729
25Hormone Antagonists13180

Interventional clinical trials:

(show all 29)
idNameStatusNCT IDPhase
1Partnership for Rapid Elimination of TrachomaCompletedNCT00792922Phase 4
2Study of Three Alternatives for Mass Treatment in Trachoma Villages of TanzaniaCompletedNCT00347607Phase 4
3Effect of Intensive Fly Control on Trachoma and Ocular Chlamydia Infection in TanzaniaCompletedNCT00347763Phase 4
4Impact of Water and Health Education Programs on Trachoma and Ocular C. Trachomatis in NigerCompletedNCT00348478Phase 4
5Trachoma Elimination Follow-upCompletedNCT00221364Phase 4
6Impact of Two Alternative Dosing Strategies for Trachoma Control in NigerCompletedNCT00618449Phase 4
7Trachoma Amelioration in Northern Amhara (TANA)CompletedNCT00322972Phase 4
8Tripartite International Research for the Elimination of TrachomaCompletedNCT01202331Phase 4
9A Trial of Non-absorbable Versus Absorbable Sutures for Trichiasis SurgeryCompletedNCT00522860Phase 4
10Study of Azithromycin to Prevent Recurrent Trichiasis Following Surgery in EthiopiaCompletedNCT00347776Phase 4
11Sanitation, Water, and Instruction in Face-washing for TrachomaRecruitingNCT02754583Phase 4
12Azithromycin to Prevent Post-discharge Morbidity and Mortality in Kenyan ChildrenRecruitingNCT02414399Phase 4
13Mortality Reduction After Oral Azithromycin: Morbidity StudyRecruitingNCT02048007Phase 4
14Mortality Reduction After Oral Azithromycin: Mortality StudyRecruitingNCT02047981Phase 4
15A Surveillance and Azithromycin Treatment for Newcomers and Travelers Evaluation: The ASANTE TrialActive, not recruitingNCT01767506Phase 4
16Water Uptake for Health in Amhara PilotActive, not recruitingNCT02373657Phase 4
17Azithromycin in Control of Trachoma IIWithdrawnNCT00286026Phase 4
18Safety Study of Combined Azithromycin, Ivermectin and Albendazole for Trachoma and Lymphatic FilariasisWithdrawnNCT01903057Phase 4
19Efficacy and Safety of 2 Dosing Regimens of T1225 Eye Drops 1.5% Versus Oral Azithromycin in Treatment of TrachomaCompletedNCT00356720Phase 3
20Nepal Elimination of Trachoma StudyWithdrawnNCT02176057Phase 2, Phase 3
21Modified Instrumentation for Surgery to Correct TrichiasisCompletedNCT00886015
22Safety of the Co-administration of Three Drugs for Trachoma and Lymphatic Filariasis EliminationCompletedNCT01586169
23Identification of TT Cases by Community Treatment Assistants: An AssessmentCompletedNCT01783743
24Fluorometholone as Ancillary Therapy for TT SurgeryCompletedNCT01949454
25A Trial of Epilation Verses Surgery for Minor TrichiasisCompletedNCT00522912
26Comparison of Ultrasonic Pachymetry With Orbscan in Corneal HazeCompletedNCT00439114
27The Effect of Oral Azithromycin in the Treatment of Chlamydial ConjunctivitisCompletedNCT01178762
28The Effect of Long-Term HEAD START Training on Surgical Skill LevelsNot yet recruitingNCT03135080
29Performance of a Photoscreener for Vision Screening in a Haitian Pediatric PopulationWithdrawnNCT02655432Early Phase 1

Search NIH Clinical Center for Trachoma

Inferred drug relations via UMLS68/NDF-RT46:


Cochrane evidence based reviews: trachoma

Genetic Tests for Trachoma

About this section

Anatomical Context for Trachoma

About this section

MalaCards organs/tissues related to Trachoma:

36
Eye, Testes, T cells, B cells, Spleen

FMA organs/tissues related to Trachoma:

17
Eye

Publications for Trachoma

About this section

Articles related to Trachoma:

(show top 50)    (show all 668)
idTitleAuthorsYear
1
In Morocco, the elimination of trachoma as a public health problem becomes a reality. (28089329)
2017
2
Prevalence of Trachoma in Schoolchildren in Brazil. (27824506)
2016
3
Cross-Sectional Surveys of the Prevalence of Follicular Trachoma and Trichiasis in The Gambia: Has Elimination Been Reached? (27643498)
2016
4
Immunohistochemical Analysis of Scarring Trachoma Indicates Infiltration by Natural Killer and Undefined CD45 Negative Cells. (27219121)
2016
5
Trachoma: Past, present and future. (27830198)
2016
6
Trachoma prevalence in rural areas of eastern Iran. (27158510)
2016
7
Nasopharyngeal Pneumococcal Serotypes Before and After Mass Azithromycin Distributions for Trachoma. (27199475)
2016
8
Prevalence of Trachoma in Car-Nicobar Island, India after Three Annual Rounds of Mass Drug Administration with Azithromycin. (27391274)
2016
9
A cluster-randomized trial to assess the efficacy of targeting trachoma treatment to children. (27956455)
2016
10
Low Prevalence of Conjunctival Infection with Chlamydia trachomatis in a Treatment-NaA^ve Trachoma-Endemic Region of the Solomon Islands. (27603015)
2016
11
Fibroblasts profiling in scarring trachoma identifies IL-6 as a functional component of a fibroblast-macrophage pro-fibrotic and pro-inflammatory feedback loop. (27321784)
2016
12
Erratum to: Short-term forecasting of the prevalence of clinical trachoma: utility of including delayed recovery and tests for infection. (27283120)
2016
13
Prevalence and factors associated with trachoma among children aged 1-9 years in Zala district, Gamo Gofa Zone, Southern Ethiopia. (27621585)
2016
14
Relationship between Community Drug Administration Strategy and Changes in Trachoma Prevalence, 2007 to 2013. (27385309)
2016
15
Australian trachoma surveillance annual report, 2013. (27522137)
2016
16
Mass drug administration of azithromycin for trachoma reduces the prevalence of genital Chlamydia trachomatis infection in the Solomon Islands. (26888658)
2016
17
Chlamydia trachomatis from Australian Aboriginal people with trachoma are polyphyletic composed of multiple distinctive lineages. (26912299)
2016
18
Prevalence of Trachoma in Niger State, North Central Nigeria: Results of 25 Population-Based Prevalence Surveys Carried Out with the Global Trachoma Mapping Project. (27918223)
2016
19
Trachoma. (26860629)
2016
20
The Global Trachoma Mapping Project: A Catalyst for Progress Against Neglected Tropical Diseases. (28030282)
2016
21
The broad benefits of trachoma elimination. (27599650)
2016
22
Sequelae from Epidemic Viral Conjunctivitis Can Be Associated with Inflammatory Trachoma in Schoolchildren? (27628039)
2016
23
The Prevalence of Trachoma in Tigray Region, Northern Ethiopia: Results of 11 Population-Based Prevalence Surveys Completed as Part of the Global Trachoma Mapping Project. (27918232)
2016
24
History of trachoma. (27939803)
2016
25
Historical Aspects of Endemic Trachoma in Peru: 1895-2000. (26766118)
2016
26
Prevalence of and Risk Factors for Trachoma in Southern Nations, Nationalities, and Peoples' Region, Ethiopia: Results of 40 Population-Based Prevalence Surveys Carried Out with the Global Trachoma Mapping Project. (27918229)
2016
27
Enhanced antibiotic distribution strategies and the potential impact of facial cleanliness and environmental improvements for the sustained control of trachoma: a modelling study. (27194136)
2016
28
Arthur Ferguson MacCallan CBE, MD, FRCS (1872-1955), trachoma pioneer and the ophthalmic campaign in Egypt 1903-1923. (27316693)
2016
29
Low Prevalence of Ocular Chlamydia trachomatis Infection and Active Trachoma in the Western Division of Fiji. (27404379)
2016
30
The World Health Organization Recommendations for Trachoma Surveillance, Experience in Nepal and Added Benefit of Testing for Antibodies to Chlamydia trachomatis pgp3 Protein: NESTS Study. (27654497)
2016
31
Prevalence of Trachoma in Benishangul Gumuz Region, Ethiopia: Results of Seven Population-Based Surveys from the Global Trachoma Mapping Project. (27918248)
2016
32
National Trachoma Assessment in the Lao People's Democratic Republic in 2013-2014. (27846362)
2016
33
Elimination of blinding trachoma in China. (27865692)
2016
34
Community seroprevalence survey for yaws and trachoma in the Western Division of Fiji. (27852877)
2016
35
The impact of climate on the abundance of Musca sorbens, the vector of trachoma. (26817815)
2016
36
Blinding Trachoma: Systematic Review of Rates and Risk Factors for Progressive Disease. (27483002)
2016
37
Trachoma in Indigenous Settlements in Brazil, 2000-2008. (27142891)
2016
38
Elimination of Trachoma-Knowing Where to Intervene. (27841722)
2016
39
Genetic Polymorphisms of TLR4 and MICA are Associated with Severity of Trachoma Disease in Tanzania. (27559544)
2016
40
Rural children active trachoma risk factors and their interactions. (27642466)
2016
41
Population-Based Trachoma Mapping in Six Evaluation Units of Papua New Guinea. (27893297)
2016
42
Prevalence of Trachoma in Gambella Region, Ethiopia: Results of Three Population-Based Prevalence Surveys Conducted with the Global Trachoma Mapping Project. (27918222)
2016
43
Mapping Trachoma in the Solomon Islands: Results of Three Baseline Population-Based Prevalence Surveys Conducted with the Global Trachoma Mapping Project. (27937043)
2016
44
Prevalence of Trachoma in Bauchi State, Nigeria: Results of 20 Local Government Area-Level Surveys. (27846369)
2016
45
The Epidemiology of Trachoma in Darfur States and Khartoum State, Sudan: Results of 32 Population-Based Prevalence Surveys. (27841721)
2016
46
Mapping Trachoma in Kaduna State, Nigeria: Results of 23 Local Government Area-Level, Population-Based Prevalence Surveys. (27918227)
2016
47
Eliminating trachoma: accelerating towards 2020. (27601799)
2016
48
Prevalence of Active and Latent Yaws in the Solomon Islands 18 Months after Azithromycin Mass Drug Administration for Trachoma. (27551787)
2016
49
Differential frequency of NKG2C/KLRC2 deletion in distinct African populations and susceptibility to Trachoma: a new method for imputation of KLRC2 genotypes from SNP genotyping data. (27312142)
2016
50
Can We Use Antibodies to Chlamydia trachomatis as a Surveillance Tool for National Trachoma Control Programs? Results from a District Survey. (26771906)
2016

Variations for Trachoma

About this section

Expression for genes affiliated with Trachoma

About this section
Search GEO for disease gene expression data for Trachoma.

Pathways for genes affiliated with Trachoma

About this section

Pathways related to Trachoma according to GeneCards Suite gene sharing:

(show all 14)
idSuper pathwaysScoreTop Affiliating Genes
19.6CTGF, TNF
2
Show member pathways
9.4IL10, TNF
39.4IL10, TNF
49.4IL10, TNF
59.4IL10, TNF
69.4IL10, TNF
79.2CTGF, ENG
89.2HLA-C, KIR2DL2, KIR2DL3
9
Show member pathways
8.9HLA-C, IL10, TNF
108.9IDO1, IL10, TNF
118.9IDO1, IL10, TNF
12
Show member pathways
8.8HLA-C, KIR2DL2, KIR2DL3, TNF
138.6ENG, IL10, TNF
14
Show member pathways
8.2HLA-C, IL10, KIR2DL2, KIR2DL3, TNF

GO Terms for genes affiliated with Trachoma

About this section

Biological processes related to Trachoma according to GeneCards Suite gene sharing:

(show all 17)
idNameGO IDScoreTop Affiliating Genes
1positive regulation of cysteine-type endopeptidase activity involved in apoptotic processGO:004328010.3CTGF, TNF
2endothelial cell apoptotic processGO:007257710.1IL10, TNF
3negative regulation of cytokine secretion involved in immune responseGO:000274010.1IL10, TNF
4negative regulation of growth of symbiont in hostGO:004413010.1IL10, TNF
5negative regulation of interleukin-6 productionGO:003271510.1IL10, TNF
6negative regulation of mitotic cell cycleGO:004593010.1IL10, TNF
7positive regulation of cytokine secretionGO:005071510.0IL10, TNF
8positive regulation of heterotypic cell-cell adhesionGO:003411610.0IL10, TNF
9positive regulation of vascular smooth muscle cell proliferationGO:190470710.0IL10, TNF
10negative regulation of T cell proliferationGO:004213010.0IDO1, IL10
11receptor biosynthetic processGO:003280010.0IL10, TNF
12extracellular matrix constituent secretionGO:007027810.0CTGF, ENG
13positive regulation of collagen biosynthetic processGO:00329679.9CTGF, ENG
14negative regulation of gene expressionGO:00106299.5CTGF, ENG, TNF
15positive regulation of protein phosphorylationGO:00019349.4CTGF, ENG, TNF
16regulation of immune responseGO:00507769.2HLA-C, KIR2DL2, KIR2DL3
17immune responseGO:00069559.2HLA-C, IL10, KIR2DL3, TNF

Sources for Trachoma

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
27GTR
28HGMD
29HMDB
30ICD10
31ICD10 via Orphanet
32ICD9CM
33IUPHAR
34KEGG
37MedGen
39MeSH
40MESH via Orphanet
41MGI
44NCI
45NCIt
46NDF-RT
49NINDS
50Novoseek
52OMIM
53OMIM via Orphanet
57PubMed
58QIAGEN
63SNOMED-CT via Orphanet
67Tumor Gene Family of Databases
68UMLS
69UMLS via Orphanet